OnCore Login

Return to Trial Database

LUN04-79

A Phase I-IIa Dose-Ranging Study of Pemetrexed (Alimta) Plus Cetuximab (Erbitux) in Patients With Recurrent Non-Small Cell Lung Cancer (NSCLC): Hoosier Oncology Group LUN04-79

Status

Study Completed

Cancer Type(s)

Lung

Study Contact

Publications

A Phase I-IIa Dose Ranging Study of Pemetrexed plus Cetuximab in Patients (pts) with Recurrent Non-Small Cell Lung Cancer (NSCLC)
  • P Bedano, M Edelman, S Nattam, D Waterhouse, J Shen, M Yu, J Harvey, J Vinson, A White, B Bottema, N Hanna
Pemetrexed plus Cetuximab in patients with Recurrent Non-Small Cell Lung Cancer (NSCLC): A Phase I/II Study
  • S Jalal, D Waterhouse, MJ Edelman, S Nattam, R Ansari, K Koneru, R Clark, A Richards, J Wu, M Yu, B Bottema, A White, N Hanna

Trial Locations

All sites in which the trial LUN04-79 being conducted in.
No data was found
  • 7676 Interactive Way, Suite 120, Indianapolis, IN 46278